company background image
CDXS

Codexis NasdaqGS:CDXS Stock Report

Last Price

US$6.44

Market Cap

US$404.0m

7D

-2.6%

1Y

-67.5%

Updated

01 Feb, 2023

Data

Company Financials +

CDXS Stock Overview

Codexis, Inc. discovers, develops, and sells enzymes and other proteins.

CDXS fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Codexis, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Codexis
Historical stock prices
Current Share PriceUS$6.44
52 Week HighUS$22.22
52 Week LowUS$4.21
Beta1.48
1 Month Change38.20%
3 Month Change12.78%
1 Year Change-67.51%
3 Year Change-60.45%
5 Year Change-21.94%
Change since IPO-51.43%

Recent News & Updates

Recent updates

Is Codexis, Inc. (NASDAQ:CDXS) Trading At A 28% Discount?

Nov 05
Is Codexis, Inc. (NASDAQ:CDXS) Trading At A 28% Discount?

Codexis appoints Kevin Norrett as chief operating officer

Oct 03

We Think Codexis (NASDAQ:CDXS) Can Afford To Drive Business Growth

Aug 23
We Think Codexis (NASDAQ:CDXS) Can Afford To Drive Business Growth

Analysts Have Just Cut Their Codexis, Inc. (NASDAQ:CDXS) Revenue Estimates By 10%

Jul 28
Analysts Have Just Cut Their Codexis, Inc. (NASDAQ:CDXS) Revenue Estimates By 10%

Codexis: Profitability, Return On Capital Are Persistent Headwinds Looking Ahead

Jul 27

Codexis gets new executive chief

Jul 18

Are Investors Undervaluing Codexis, Inc. (NASDAQ:CDXS) By 35%?

Jul 06
Are Investors Undervaluing Codexis, Inc. (NASDAQ:CDXS) By 35%?

Why Codexis, Inc. (NASDAQ:CDXS) Could Be Worth Watching

May 10
Why Codexis, Inc. (NASDAQ:CDXS) Could Be Worth Watching

Codexis: A Company Rooting Itself In A Blossoming Market

Apr 18

We're Not Worried About Codexis' (NASDAQ:CDXS) Cash Burn

Apr 09
We're Not Worried About Codexis' (NASDAQ:CDXS) Cash Burn

Does This Valuation Of Codexis, Inc. (NASDAQ:CDXS) Imply Investors Are Overpaying?

Mar 14
Does This Valuation Of Codexis, Inc. (NASDAQ:CDXS) Imply Investors Are Overpaying?

Codexis (NASDAQ:CDXS) Is In A Strong Position To Grow Its Business

Dec 24
Codexis (NASDAQ:CDXS) Is In A Strong Position To Grow Its Business

Codexis, Inc. (NASDAQ:CDXS) Shares Could Be 39% Below Their Intrinsic Value Estimate

Nov 07
Codexis, Inc. (NASDAQ:CDXS) Shares Could Be 39% Below Their Intrinsic Value Estimate

Upgrade: Analysts Just Made A Notable Increase To Their Codexis, Inc. (NASDAQ:CDXS) Forecasts

Aug 08
Upgrade: Analysts Just Made A Notable Increase To Their Codexis, Inc. (NASDAQ:CDXS) Forecasts

Companies Like Codexis (NASDAQ:CDXS) Are In A Position To Invest In Growth

Aug 03
Companies Like Codexis (NASDAQ:CDXS) Are In A Position To Invest In Growth

Codexis price target raised at H.C. Wainwright citing new purchase order

Jun 18

Here's Why We Think Codexis, Inc.'s (NASDAQ:CDXS) CEO Compensation Looks Fair for the time being

Jun 09
Here's Why We Think Codexis, Inc.'s (NASDAQ:CDXS) CEO Compensation Looks Fair for the time being

Is There Now An Opportunity In Codexis, Inc. (NASDAQ:CDXS)?

May 11
Is There Now An Opportunity In Codexis, Inc. (NASDAQ:CDXS)?

Codexis EPS beats by $0.07, beats on revenue

May 06

Companies Like Codexis (NASDAQ:CDXS) Are In A Position To Invest In Growth

Apr 15
Companies Like Codexis (NASDAQ:CDXS) Are In A Position To Invest In Growth

Codexis (NASDAQ:CDXS) Shareholders Have Enjoyed A Whopping 578% Share Price Gain

Mar 20
Codexis (NASDAQ:CDXS) Shareholders Have Enjoyed A Whopping 578% Share Price Gain

Estimating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

Feb 22
Estimating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

What Is Codexis, Inc.'s (NASDAQ:CDXS) Share Price Doing?

Jan 27
What Is Codexis, Inc.'s (NASDAQ:CDXS) Share Price Doing?

Shareholder Returns

CDXSUS Life SciencesUS Market
7D-2.6%-0.03%1.7%
1Y-67.5%-15.2%-12.5%

Return vs Industry: CDXS underperformed the US Life Sciences industry which returned -15.2% over the past year.

Return vs Market: CDXS underperformed the US Market which returned -12.5% over the past year.

Price Volatility

Is CDXS's price volatile compared to industry and market?
CDXS volatility
CDXS Average Weekly Movement12.1%
Life Sciences Industry Average Movement11.7%
Market Average Movement6.9%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: CDXS is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: CDXS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2002261Stephen Dillyhttps://www.codexis.com

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services.

Codexis, Inc. Fundamentals Summary

How do Codexis's earnings and revenue compare to its market cap?
CDXS fundamental statistics
Market CapUS$403.98m
Earnings (TTM)-US$31.18m
Revenue (TTM)US$132.72m

3.2x

P/S Ratio

-13.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CDXS income statement (TTM)
RevenueUS$132.72m
Cost of RevenueUS$113.15m
Gross ProfitUS$19.57m
Other ExpensesUS$50.74m
Earnings-US$31.18m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.47
Gross Margin14.74%
Net Profit Margin-23.49%
Debt/Equity Ratio0%

How did CDXS perform over the long term?

See historical performance and comparison